Philippe Beaune
- Pharmacology top 0.01%
- Pharmacogenetics and Drug Metabolism 184
- Drug-Induced Hepatotoxicity and Protection 40
- Transplantation top 0.2%
- Renal Transplantation Outcomes and Treatments 24
- Oncology top 0.2%
- Drug Transport and Resistance Mechanisms 61
- Biochemistry top 0.1%
- Eicosanoids and Hypertension Pharmacology 32
- Cancer Research top 0.5%
- Carcinogens and Genotoxicity Assessment 19
-
- Glutathione Transferases and Polymorphisms 30
-
- Pharmacological Effects and Toxicity Studies 24
- Co-authors
- F. Peter GuengerichMarie‐Anne LoriotIsabelle de WaziersP. KremersPierre Laurent‐PuigJean‐Charles GautierChristophe LegendreDany Anglicheau
- Cited by
- PharmacologyTransplantationOncology
- Journals
- Biochemical Pharmacology (14 papers)Molecular Pharmacology (12 papers)Biochemical and Biophysical Research Communications (9 papers)
- Partner nations
- FranceUnited StatesGermany
In The Last Decade
Philippe Beaune
345 papers receiving 18.1k citations
Hit Papers
Peers
Comparison fields: 5 of 165
- Pharmacology 9.2k
- Transplantation 1.2k
- Oncology 5.7k
- Biochemistry 1.4k
- Cancer Research 1.8k
Countries citing papers authored by Philippe Beaune
This map shows the geographic impact of Philippe Beaune's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Beaune with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Beaune more than expected).
Fields of papers citing papers by Philippe Beaune
This network shows the impact of papers produced by Philippe Beaune. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Beaune. The network helps show where Philippe Beaune may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Philippe Beaune, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 11 | |
| 2 | Une architecture orientée services pour l'OLAP Spatial. | 2016 | 1 |
| 3 | 2015 | 54 | |
| 4 | 2014 | 1 | |
| 5 | 2014 | 28 | |
| 6 | 2013 | 40 | |
| 7 | Pharmacogenetic assessment of toxicity and outcome in patients with metastatic colorectal cancer treated with LV5FU2, FOLFOX, and FOLFIRI: FFCD 2000-05 | 2010 | 3 |
| 8 | 2005 | 58 | |
| 9 | 2003 | 33 | |
| 10 | Towards Open Distributed Information Systems By the Way of a Multi-Agent Conception Framework | 2000 | 1 |
| 11 | 1998 | 56 | |
| 12 | 1996 | 10 | |
| 13 | 1996 | 41 | |
| 14 | 1996 | 36 | |
| 15 | 1995 | 49 | |
| 16 | 1994 | 10 | |
| 17 | 1992 | 56 | |
| 18 | 1992 | 101 | |
| 19 | 1991 | 38 | |
| 20 | 1991 | 162 |
About Philippe Beaune
Philippe Beaune is a scholar working on Pharmacology, Transplantation and Biochemistry, having authored 352 papers that have together received 18.7k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (184 papers), Drug Transport and Resistance Mechanisms (61 papers), Drug-Induced Hepatotoxicity and Protection (40 papers), Eicosanoids and Hypertension Pharmacology (32 papers), Glutathione Transferases and Polymorphisms (30 papers), Renal Transplantation Outcomes and Treatments (24 papers), Pharmacological Effects and Toxicity Studies (24 papers) and Carcinogens and Genotoxicity Assessment (19 papers). The work is most often cited by research in Pharmacology (9.2k citations), Transplantation (1.2k citations) and Oncology (5.7k citations). Philippe Beaune has collaborated with scholars based in France, United States and Germany. Frequent co-authors include F. Peter Guengerich, Marie‐Anne Loriot, Isabelle de Waziers, P. Kremers, Pierre Laurent‐Puig, Jean‐Charles Gautier, Christophe Legendre, Dany Anglicheau, Daniel Mansuy and F. Berthou. Their work appears in journals such as Biochemical Pharmacology, Molecular Pharmacology, Biochemical and Biophysical Research Communications, Journal of Pharmacology and Experimental Therapeutics and Drug Metabolism and Disposition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.